Nervous System Neoplasm — Trials

Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,873 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 760 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02315326	Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)	completed	Phase 1 / Phase 2	93	Memorial Sloan Kettering Cancer CenterOTHER	1	Feb 2, 2026	clinicaltrials
NCT04401774	Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy	completed	Phase 2	14	Memorial Sloan Kettering Cancer CenterOTHER